Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription

Articles published in Mol Cell Biochem

Retrieve available abstracts of 27 articles:
HTML format

Single Articles

    August 2023
  1. WANG N, Chen C, Ren J, Dai D, et al
    MicroRNA delivery based on nanoparticles of cardiovascular diseases.
    Mol Cell Biochem. 2023 Aug 5. doi: 10.1007/s11010-023-04821.
    PubMed     Abstract available

  2. LI D, Gao S
    The interplay between T lymphocytes and macrophages in myocardial ischemia/reperfusion injury.
    Mol Cell Biochem. 2023 Aug 4. doi: 10.1007/s11010-023-04822.
    PubMed     Abstract available

  3. DRAGASEVIC N, Savic M, Mihajlovic K, Zivkovic V, et al
    The impact of different diuretics on regression of myocardial reperfusion injury in spontaneously hypertensive rats.
    Mol Cell Biochem. 2023;478:1803-1812.
    PubMed     Abstract available

  4. MUSTAFA T, Khan I, Iqbal H, Usman S, et al
    Rutin and quercetagetin enhance the regeneration potential of young and aging bone marrow-derived mesenchymal stem cells in the rat infarcted myocardium.
    Mol Cell Biochem. 2023;478:1759-1770.
    PubMed     Abstract available

    July 2023
  5. WU C, Chen Y, Wang Y, Xu C, et al
    The m(6)A methylation enzyme METTL14 regulates myocardial ischemia/reperfusion injury through the Akt/mTOR signaling pathway.
    Mol Cell Biochem. 2023 Jul 12. doi: 10.1007/s11010-023-04808.
    PubMed     Abstract available

  6. ZAFAR M, Malik IR, Mirza MR, Awan FR, et al
    Mass-spectrometric analysis of APOB polymorphism rs1042031 (G/T) and its influence on serum proteome of coronary artery disease patients: genetic-derived proteomics consequences.
    Mol Cell Biochem. 2023 Jul 6. doi: 10.1007/s11010-023-04797.
    PubMed     Abstract available

    June 2023
  7. SALAMA ABM, Abouleisa RRE, Ou Q, Tang XL, et al
    Transient gene therapy using cell cycle factors reverses renin-angiotensin-aldosterone system activation in heart failure rat model.
    Mol Cell Biochem. 2023;478:1245-1250.
    PubMed     Abstract available

    May 2023
  8. BAKHSHI A, Khani M, Alipour Parsa S, Khaheshi I, et al
    Investigating the expression level of miR-17-3p, miR-101-3p, miR-335-3p, and miR-296-3p in the peripheral blood of patients with acute myocardial infarction.
    Mol Cell Biochem. 2023 May 24. doi: 10.1007/s11010-023-04766.
    PubMed     Abstract available

  9. SHARMA S, Sharma D, Dhobi M, Wang D, et al
    An insight to treat cardiovascular diseases through phytochemicals targeting PPAR-alpha.
    Mol Cell Biochem. 2023 May 12. doi: 10.1007/s11010-023-04755.
    PubMed     Abstract available

  10. SHIZUKUDA Y, Rosing DR
    Hereditary hemochromatosis with homozygous C282Y HFE mutation: possible clinical model to assess effects of elevated reactive oxygen species on the development of cardiovascular disease.
    Mol Cell Biochem. 2023 May 3. doi: 10.1007/s11010-023-04726.
    PubMed     Abstract available

    March 2023
  11. BAI Y, Bai J, Lu P, Jing YM, et al
    Hirudin ameliorates myocardial ischemia-reperfusion injury in a rat model of hemorrhagic shock and resuscitation: roles of NLRP3-signaling pathway.
    Mol Cell Biochem. 2023 Mar 29. doi: 10.1007/s11010-023-04717.
    PubMed     Abstract available

  12. KUKREJA RC, Wang R, Koka S, Das A, et al
    Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19?
    Mol Cell Biochem. 2023;478:679-696.
    PubMed     Abstract available

    October 2022
  13. TANG J, Tang QX, Liu S
    METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction.
    Mol Cell Biochem. 2022 Oct 25. pii: 10.1007/s11010-022-04570.
    PubMed     Abstract available

    September 2022
  14. NONG Y, Guo Y, Ou Q, Gumpert A, et al
    PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction.
    Mol Cell Biochem. 2022 Sep 17. pii: 10.1007/s11010-022-04561.
    PubMed     Abstract available

  15. JIANG T, You H, You D, Zhang L, et al
    Retraction Note: A miR1275 mimic protects myocardiocyte apoptosis by regulating the Wnt/NFkappaB pathway in a rat model of myocardial ischemia-reperfusioninduced myocardial injury.
    Mol Cell Biochem. 2022 Sep 13. pii: 10.1007/s11010-022-04547.

  16. BORA VR, Gohel D, Singh R, Patel BM, et al
    Evaluation of selected antidiabetics in cardiovascular complications associated with cancer cachexia.
    Mol Cell Biochem. 2022 Sep 13. pii: 10.1007/s11010-022-04552.
    PubMed     Abstract available

    July 2022
  17. ZHONG Z, Luo XY, Xiang P, Ji HH, et al
    MRTF-A alleviates myocardial ischemia reperfusion injury by inhibiting the inflammatory response and inducing autophagy.
    Mol Cell Biochem. 2022 Jul 12. pii: 10.1007/s11010-022-04510.
    PubMed     Abstract available

    June 2022
  18. TODOROVIC D, Stojanovic M, Gopcevic K, Medic A, et al
    Effects of four weeks lasting aerobic physical activity on cardiovascular biomarkers, oxidative stress and histomorphometric changes of heart and aorta in rats with experimentally induced hyperhomocysteinemia.
    Mol Cell Biochem. 2022 Jun 27. pii: 10.1007/s11010-022-04503.
    PubMed     Abstract available

    May 2022
  19. JAKOVLJEVIC V, Vorobyev S, Bolevich S, Morozova E, et al
    Dose-dependent effects of perfluorocarbon-based blood substitute on cardiac function in myocardial ischemia-reperfusion injury.
    Mol Cell Biochem. 2022 May 29. pii: 10.1007/s11010-022-04479.
    PubMed     Abstract available

    March 2022
  20. ZHENG Y, Li X, Zhang F, Zhao B, et al
    Protective effect of nicorandil against myocardial ischemia/reperfusion injury mediated via IL33/ST2 signaling pathway.
    Mol Cell Biochem. 2022 Mar 28. pii: 10.1007/s11010-022-04418.
    PubMed     Abstract available

  21. SRIVASTAVA A, Rockman-Greenberg C, Sareen N, Lionetti V, et al
    An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning beta-cell survival and cardiovascular conditions in diabetic patients.
    Mol Cell Biochem. 2022 Mar 2. pii: 10.1007/s11010-022-04396.
    PubMed     Abstract available

    February 2022
  22. LIU N, Xie L, Xiao P, Chen X, et al
    Cardiac fibroblasts secrete exosome microRNA to suppress cardiomyocyte pyroptosis in myocardial ischemia/reperfusion injury.
    Mol Cell Biochem. 2022 Feb 4. pii: 10.1007/s11010-021-04343.
    PubMed     Abstract available

  23. THAKKAR H, Vincent V, Roy A, Gautam AK, et al
    Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids.
    Mol Cell Biochem. 2022;477:559-570.
    PubMed     Abstract available

    January 2022
  24. SHARMA S, Sharma U
    Exosomes in cardiovascular diseases: a blessing or a sin for the mankind.
    Mol Cell Biochem. 2022 Jan 22. pii: 10.1007/s11010-021-04328.
    PubMed     Abstract available

  25. EYYUPKOCA F, Ercan K, Kiziltunc E, Ugurlu IB, et al
    Determination of microRNAs associated with adverse left ventricular remodeling after myocardial infarction.
    Mol Cell Biochem. 2022 Jan 20. pii: 10.1007/s11010-021-04330.
    PubMed     Abstract available

    November 2021
  26. TANG XL, Wysoczynski M, Gumpert AM, Li Y, et al
    Effect of intravenous cell therapy in rats with old myocardial infarction.
    Mol Cell Biochem. 2021 Nov 16. pii: 10.1007/s11010-021-04283.
    PubMed     Abstract available

  27. JU J, Song YN, Chen XZ, Wang T, et al
    circRNA is a potential target for cardiovascular diseases treatment.
    Mol Cell Biochem. 2021 Nov 15. pii: 10.1007/s11010-021-04286.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.